Finlee

Finlee (Dabrafenib) is an oral medication used to treat certain types of cancer. This prescription drug is designed to target specific genetic mutations, offering a tailored approach to cancer therapy.

Finlee (Dabrafenib) is primarily used in the treatment of advanced or metastatic melanoma with a specific BRAF V600 mutation. It may also be used for other types of cancer that harbor the same genetic mutation. Patients should consult their healthcare provider to determine if Finlee is suitable for their condition.

Common effects of Finlee may include fatigue, fever, joint pain, and skin-related issues such as rash or hyperkeratosis. Some users may also experience nausea, vomiting, or changes in hair or nail quality. These effects can vary in intensity and duration among individuals.

Finlee should be handled with care and stored as directed. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Patients should inform their doctor about any other medications they are taking to avoid potential interactions.

Finlee may interact with certain medications, including strong CYP3A4 inducers or inhibitors. It is advisable to avoid grapefruit and grapefruit juice, as they can affect the metabolism of Dabrafenib. Always consult a healthcare provider before starting or stopping any medication while taking Finlee.